zum Inhalt springen

Fachbereich Veterinärmedizin


Service-Navigation

    Publikationsdatenbank

    Evaluation of different blood parameters from endurance horses competing at 160 km (2021)

    Art
    Zeitschriftenartikel / wissenschaftlicher Beitrag
    Autoren
    Ertelt, Antonia (WE 17)
    Merle, Roswitha (WE 16)
    Stumpff, Friederike (WE 2)
    Bollinger, Lena (WE 17)
    Liertz, Sarah (WE 17)
    Weber, Corinna
    Gehlen, Heidrun (WE 17)
    Quelle
    Journal of equine veterinary science
    Bandzählung: 104
    Seiten: Artikel 103687
    ISSN: 0737-0806
    Sprache
    Englisch
    Verweise
    URL (Volltext): https://linkinghub.elsevier.com/retrieve/pii/S0737080621003178
    DOI: 10.1016/j.jevs.2021.103687
    Pubmed: 34416987
    Kontakt
    Institut für Veterinär-Epidemiologie und Biometrie

    Königsweg 67
    14163 Berlin
    +49 30 838 56034
    epi@vetmed.fu-berlin.de

    Abstract / Zusammenfassung

    The purpose of this study was to assess a change in different blood parameters before and after a 160 km endurance race and to evaluate differences in cardiac biomarkers between horses that completed the race and horses that did not. The study population consisted of 52 healthy endurance horses. Horses participating in the study were assigned to three groups: horses that successfully completed the race ("finishers"), horses that failed to qualify at the veterinary check for primarily metabolic reasons ("metabolic") and horses that failed to qualify at the veterinary check for primarily gait related reasons ("gait related"). The latter two groups were combined to form a final group of "non-finishers" that were excluded for either "gait related" or "metabolic" disorders. Venous blood samples were taken before and after the endurance race. Serum and EDTA-plasma were analyzed for cardiac troponin I (cTNI), heart fatty acid binding protein (HFABP), alpha-hydroxybutyrate dehydrogenase (α-HBDH), atrial natriuretic peptide (ANP), lactate dehydrogenase (LDH), symmetric dimethylarginine (SDMA) and asymmetric dimethylarginine (ADMA). Lactate dehydrogenase (P = .001), SDMA (P= .001) and ADMA (P= .002) increased significantly after the endurance race in the finisher group. A significant increase in cTNI and α-HBDH concentration after the endurance race compared to the values before the endurance race was detected in the finisher (P= .001, P= .001) and gait related group (P= .002, P= .007). The longer the distance completed, the more these five blood parameters increased. No differences between the groups could be found and none of the measured blood parameters showed significant differences among groups before or after racing.